Ferrer, Lanileah G.
HRN: 24-53-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2024
CLINDAMYCIN 300MG (CAP)
04/01/2024
04/08/2024
PO
300mg
TID
S/p Manual Vacuum Aspiration Biopsy
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes